Faron Pharmaceuticals Oy

ARDSAVI

Pharmaceutical preparations for treatment and prevention of ischemic conditions, inflammation and organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions and allergic conditions; pharmaceutical preparations for treatment and prevention of multi-organ failure, and acute lung injury and acute respiratory distress syndrome in adults, adolescents, children, infants and neonates; sanitary preparations for medical purposes;

ARDSIVA

Pharmaceutical preparations for treatment and prevention of ischemic conditions, inflammation and organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions and allergic conditions; pharmaceutical preparations for treatment and prevention of multi-organ failure, and acute lung injury and acute respiratory distress syndrome in adults, adolescents, children, infants and neonates; sanitary preparations for medical purposes;

BEXCLEVY

Pharmaceuticals; medical preparations; veterinary preparations; sanitary preparations for medical purposes; pharmaceutical preparations and substances for the treatment of cancer; tumor suppressing agents; antineoplastics; anti-cancer preparations; compounds for treating cancer; antibodies; biological preparations for medical purposes; adjuvants for medical purposes; vaccine adjuvants; anti-neoplastic preparations of chemical origin; anti-neoplastic preparations of microbial origin; antigens; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical use; immunomodulators; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the prevention of disorders of the immune system; serotherapeutic medicines; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for use in hematology;

BEXIGNUS

Pharmaceuticals; medical preparations; veterinary preparations; sanitary preparations for medical purposes; pharmaceutical preparations and substances for the treatment of cancer; tumor suppressing agents; antineoplastics; anti-cancer preparations; compounds for treating cancer; antibodies; biological preparations for medical purposes; adjuvants for medical purposes; vaccine adjuvants; anti-neoplastic preparations of chemical origin; anti-neoplastic preparations of microbial origin; antigens; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical use; immunomodulators; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the prevention of disorders of the immune system; serotherapeutic medicines; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for use in hematology;

CLEVEGEN

Medical and veterinary preparations to prevent inflammation and cancer growth and spread; pharmaceutical preparations for the treatment of cancer; tumor suppressing agents; antineoplastics; anti-cancer preparations; compounds for treating cancer; antibodies for medical use to treat inflammation and cancer growth and spread;The wording CLEVEGEN has no meaning in a foreign language.;

ERARDS

Pharmaceutical preparations for treatment and prevention of ischemic conditions, inflammation and organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions and allergic conditions; pharmaceutical preparations for treatment and prevention of multi-organ failure, and acute lung injury and acute respiratory distress syndrome in adults, adolescents, children, infants and neonates; sanitary preparations for medical purposes;

FARBETIC

pharmaceutical preparations, namely, prescription drugs for the treatment or prevention of metabolic disorders or their complications;

FARON

Pharmaceutical research and development; Development of pharmaceutical preparations and medicines; Conducting clinical trials for others; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical research; all the aforementioned services relating to pharmaceutical preparations for treatment and prevention of ischemic conditions, inflammations and organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions and allergic conditions, or to pharmaceutical preparations for treatment and prevention of multiorgan failure, acute lung injury and acute respiratory distress syndrome in adults, adolescents, children, infants and neonates, or to medical and veterinary preparations to prevent inflammations and cancer growth and spread, or to pharmaceutical preparations for the treatment of cancer, or to tumor suppressing agents, or to antineoplastics, or to anti-cancer preparations, or to compounds for treating cancer, or to antibodies for medical use to treat inflammation and cancer growth and spread, or to adjuvants for medical purposes, or to vaccine adjuvants;

HAEMATOKINE

Pharmaceuticals, medical and veterinary preparations for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; Sanitary preparations for medical purposes; Stem cells for medical or veterinary use; Stem cells for medical purposes; Tumor suppressing agents; Pharmaceutical preparations, namely, antineoplastics; Anti-neoplastic preparations of chemical origin, namely, pharmaceutical preparations for hematological malignancies, bone marrow dysfunction or suppressions; Anti-neoplastic preparations of microbial origin, namely, pharmaceutical preparations for hematological malignancies, bone marrow dysfunction or suppressions; Anti-cancer preparations; Compounds for treating cancer, namely, anti-cancer preparations; Antibodies for medical purposes for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; Antibodies for medical use to treat inflammation and cancer growth and spread; Adjuvants for medical purposes; Vaccine adjuvants; Biological adjuvants for medical purposes; Anti-inflammatories; Antigens, namely, tumour antigens for medical diagnostic purposes; Biological preparations for the treatment of cancer; Biopharmaceuticals for the treatment of cancer; Biotechnological preparations for medical use, namely, biological preparations for the treatment of conditions associated with poor production of hematopoietic stem cells; Culture media for medical use, namely, culture media for use in augmentation of blood cells, bone marrow and tissues for medical purposes; Media for bacteriological cultures; Cell growth media for growing cells for medical use; Biological preparations for medical purposes, namely, biological preparations for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; Mixed biological preparations for medical purposes, namely, mixed biological preparations for the prevention and treatment of infectious diseases; Biological preparations for veterinary purposes, namely, biological preparations for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; Pharmaceutical preparations, namely, immunomodulators; Immunostimulants; Injectable pharmaceuticals for treatment of hematological malignancies, bone marrow dysfunction or suppressions; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for activating cellular function; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention of tumours; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances with anti-inflammatory properties for treatment of hematological malignancies, bone marrow dysfunction or suppressions; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for use in hematology; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of disorders caused by bacteria; Pharmaceutical preparations for the treatment of diseases caused by bacteria; Pharmaceutical preparations for the prevention of disorders of the respiratory system; Pharmaceutical preparations for the prevention of inflammatory disorders; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for the prevention of inflammatory diseases; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in tissue transplantation; Pharmaceutical products for the treatment of bone diseases; Regulatory proteins for medical use, namely, protein arrays for medical diagnosis purposes; Serotherapeutic medicines, namely, pharmaceutical preparations for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; Synthetic peptides for pharmaceutical purposes for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; Pharmaceutical products for treating respiratory diseases; Pharmaceutical compounds for treating respiratory diseases; Pharmaceutical preparations for treating respiratory diseases; Pharmaceutical compounds for treating correlated pulmonary syndromes; Pharmaceutical preparations for treatment and prevention of ischemic conditions, inflammation and organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions and allergic conditions; Pharmaceutical preparations for treatment and prevention of multi-organ failure, acute lung injury and acute respiratory distress syndrome in adults, adolescents, children, infants and neonates;Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; Biological preparations for use in industry and science; Media for cell culture for use in the biotechnological industry, namely, cell culture media for scientific and research use; Media for cell culture for use in non-medical research laboratories, namely, cell culture media for laboratory use; Biological preparation for use in cell cultures other than for medical or veterinary use; Culture media for microbiology, for scientific and research use; Cell growth media for growing cells for scientific use; Biological preparation for use in cell cultures, other than for medical or veterinary use; Cultures of cell media other than for medical or veterinary use, namely culture media for scientific and research use; Cultures of microorganisms, other than for medical and veterinary use; Blood culture media being cell culture media for scientific use; Biological preparations for use in cell cultures, other than for medical or veterinary purposes; Stem cells, other than for medical or veterinary purposes; Stem cells for scientific purposes; Stem cells for research purposes;

HEXARDSA

Pharmaceutical preparations for treatment and prevention of ischemic conditions, inflammation and organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions and allergic conditions; pharmaceutical preparations for treatment and prevention of multi-organ failure, and acute lung injury and acute respiratory distress syndrome in adults, adolescents, children, infants and neonates; sanitary preparations for medical purposes;

LUNSAVI

Pharmaceuticals, medical and veterinary preparations for the treatment of diseases and disorders of the lung;

TRAUMAKINE

Pharmaceutical preparations for treatment or prevention of traumas, inflammation, organ damages resulting from tissue traumas, reperfusion injuries, cancer or cancer metastasis, or inflammatory conditions, multi-organ failure, acute lung injury and acute respiratory distress syndrome in adults and newborn babies; veterinary preparations for treatment of cattle, horses, dogs and cats for treatment or prevention of traumas, inflammation, organ damages resulting from tissue traumas, reperfusion injuries, cancer or cancer metastasis, or inflammatory conditions, multi-organ failure, acute lung injury and acute respiratory distress syndrome in adults and newborn animals;

TRAUMAKINE

Pharmaceutical preparations for treatment and prevention of ischemic conditions, inflammation and organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions and allergic conditions; pharmaceutical preparations for treatment and prevention of multiorgan failure, and acute lung injury and acute respiratory distress syndrome in adults and newborn babies; veterinary preparations for treatment of cattle, horses, dogs and cats for treatment and prevention of ischemic conditions, inflammation and organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions and allergic conditions; veterinary preparations for treatment of cattle, horses, dogs and cats for treatment and prevention of multi-organ failure, and acute lung injury and acute respiratory distress syndrome in adult and newborn animals;The wording TRAUMAKINE has no meaning in a foreign language.;